| NCT Number | NCT05502224 |
| Lead Sponsor | Jules Bordet Institute |
| Conditions | Breast Cancer, Germ Cell Tumor |
| Enrollment | 50 participants |
| Start Date | 2022-08-19 |
| Primary Completion | 2026-09 (estimated) |
| Study Completion | 2027-09 (estimated) |
| Updated on ClinicalTrials.gov | 2022-11-08 |